|
Variable
|
No. of patients
|
Over survival
|
P
|
|---|
|
Median ± SE
|
|---|
|
Cytogenetics
|
|
Favorable
|
50
|
46.664 ± 3.717
|
<0.001
|
|
Intermediate
|
27
|
29.220 ± 3.188
| |
|
Unfavorable
|
28
|
11.161 ± 1.827
| |
|
FAB
|
|
M1–M6
|
93
|
36.113 ± 2.885
|
<0.001
|
|
M7
|
12
|
8.542 ± 1.820
| |
|
Leukocyte (/μl)
|
|
> 10,000
|
61
|
30.220 ± 2.974
|
0.803
|
|
≤ 10,000
|
44
|
33.631 ± 4.063
| |
|
MRD
|
|
< 0.25 %
|
49
|
53.627 ± 3.151
|
<0.001
|
|
≥ 0.25 %
|
56
|
18.893 ± 2.425
| |
|
GATA4 expression
|
|
Low <12.420
|
53
|
32.130 ± 3.385
|
0.769
|
|
High ≥12.420
|
52
|
34.765 ± 3.941
| |
|
GATA4 methylation
|
|
Negative
|
46
|
39.141 ± 3.554
|
0.014
|
|
Positive
|
59
|
24.264 ± 3.671
| |
